What development phase is Oridonin in?

Oridonin is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Oridonin

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	Oridonin
Sponsor	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Effect of Inflammasome Inhibitor on hsCRP in Patients After PCI (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Oridonin CI brief — competitive landscape report
Oridonin updates RSS · CI watch RSS
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology portfolio CI